Gene Query: COX20

Dataset Description Geneva Score
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 72.62
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 54.8
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 43.38
Crizotinib v. DMSO in SW480 cells 25.42
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 23.8
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 22.68
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 22.49
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 22.42
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 21.07
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 20.8
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 20.53
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 20.09
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 20.06
Global expression profiles in cardiac progenitor cells generated by ISX-9 19.7
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 19.7
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 19.09
Differentiation enhances Zika virus infection in neuronal brain cells 18.67
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 18.58
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 18.38
Targeting MTHFD2 in Acute Myeloid Leukemia 17.95
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 17.31
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 17.31
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 16.24
HNRNPL and its RNA Targets in Prostate Cancer 16.24
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 16.16
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 15.53
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 15.25
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 14.95
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 14.95
4sU-seq of HFF exposed to salt and heat stress 14.48
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 14.16
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 14.13
TT-Seq captures the human transient transcriptome 14.06
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 13.94
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 13.06
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 12.82
Oncogenic MYC induces a dependency on the spliceosome in human cancer 12.62
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 12.55
Active translatome profiling with RiboLace in MCF7 cells 12.39
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 12.18
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 11.83
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 11.59
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 11.59
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 11.47
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 11.45
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 11.38
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.35
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 11.31
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 11.31
Recovery and analysis of nascent RNA 11.29
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 11.29
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 10.91
Peptidomimetic blockade of MYB in acute myeloid leukemia 10.91
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 10.58
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 10.47
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 10.4
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 10.39
RNA-Seq with and without RNase treatment in PCa cell lines 10.37
Gene expression changes upon drug withdrawal (Mel888 cell line) 10.31
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 10.19
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.95
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 9.9
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 9.9
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 9.77
Effect of mitochondria deficiency on senescence-associated gene expression 9.76
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 9.76
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 9.74
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 9.74
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 9.73
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 9.69
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.66
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 9.59
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 9.49
ARS2 is a general suppressor of pervasive transcription [RNAseq] 9.45
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 9.42
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.38
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 9.38
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.35
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.35
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 9.32
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.27
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.11
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 9.03
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 8.94
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 8.94
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 8.91
Transcriptomic analysis of LSD1 8.89
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.84
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.84
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.82
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.82
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 8.8
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 8.78
Gene expression in PANC1 cells treated with Rakicidin 8.77
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.71
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 8.53
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 8.51
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 8.42
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 8.26
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 8.1
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 8.04
Dtx3L and Androgen Signaling in Prostate Cancer 8.03
Examining serotonergic neuron differentiation from human iPSCs 7.76
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.75
Global analysis of enhancer targets: Mosaic-seq 7.73
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 7.69
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 7.69
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.65
hnRNP C is a key regulator of protein synthesis in mitosis 7.62
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 7.52
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 7.47
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 7.46
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 7.46
CROP-Seq in Primary Human T Cells 7.41
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 7.38
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.37
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 7.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.34
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 7.29
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.25
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 7.25
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 7.2
Proteomics identifies a marker signature of MAPKi resistance in melanoma 7.19
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 7.15
RNA-seq analysis of AML cells in response to ASLAN003 7.13
Rorc disruption in human FG pancreatic cancer cells 7.1
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.09
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 7.08
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.08
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.08
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.05
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 6.98
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.98
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 6.97
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 6.96
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 6.9
Gene expression changes caused by KRAS in MCF-10A 6.89
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.86
Single-nucleotide-resolution mapping of HBV promoters using CAGE 6.86
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.77
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 6.74
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 6.74
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 6.74
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.73
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.73
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 6.72
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 6.72
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 6.71
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.7
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 6.7
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 6.68
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 6.61
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.58
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 6.56
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.55
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 6.54
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 6.54
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 6.53
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.52
Region-specific Innate Antiviral Responses of the Human Epididymis 6.51
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 6.46
HEK293 Heat-shock experiment 6.43
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.41
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.38
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 6.37
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 6.29
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 6.29
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 6.28
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 6.28
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.27
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.25
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.22
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 6.2
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.17
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 6.16
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.13
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.13
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.12
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.12
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.08
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.08
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 6.08
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 6.07
SUV420H2 knockdown in PANC-1 6.06
Cleavage Factor Im as a key regulator of 3’ UTR length 6.06
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 6.02
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.97
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 5.95
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 5.95
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 5.95
AR-independent prostate cancer is sustained through FGF signaling 5.94
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 5.94
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.91
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 5.89
Silencing p300 in MCF7 cells to study expression and alternative splicing 5.83
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.82
A sister of NANOG regulates genes expressed in pre-implantation human development 5.82
RNA-seq of YB5 cells treated with Proscillaridin A 5.81
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.78
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.78
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.76
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.72
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.71
scRNASeq analysis of cycling cardiomyocytes 5.7
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 5.7
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 5.7
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 5.67
R430: A potent inbibitor of DNA and RNA viruses 5.66
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 5.63
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 5.63
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.63
Transcriptional effect of ETV1 knockdown in melanoma cells 5.63
EWS-Fli and LNC regulated genes in comparison to GFP samples 5.61
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 5.6
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 5.6
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 5.6
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.53
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.52
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 5.51
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 5.48
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.48
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 5.42
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 5.42
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 5.42
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.42
Functional role of SLIT2 and ROBO1 in trophoblasts 5.4
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 5.39
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 5.39
single cell RNA-seq from GM12878 (ENCSR673UIY) 5.37
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.36
SLIGRL-induced gene expression changes in NHEK cells 5.31
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.3
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.25
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.25
RNA polymerase in pre-B-ALL cell lines 5.2
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.19
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 5.19
RNA-sequencing of healthy human skeletal myocytes 5.18
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.17
Regulation of Lipids is Central to Replicative Senescence 5.13
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 5.12
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 5.12
Hypoxic transcriptome of SQ20B human head and neck cancer cells 5.09
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.06
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 5.0
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 5.0
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 4.98
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 4.96
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 4.95
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 4.93
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 4.92
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 4.92
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 4.89
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.87
Exploring ILF2 regulatory genes by next-generation sequencing 4.86
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 4.84
Global Mapping of Human RNA-RNA Interactions 4.84
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.81
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.79
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 4.77
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 4.75
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 4.71
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.71
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.7
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.7
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 4.69
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.69
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.69
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.68
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.61
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.53
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 4.5
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 4.5
SF3B1 Degron knockdown RNA-seq 4.49
PRDM1 inhibits proliferation of human colon cancer organoids 4.46
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.44
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.4
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 4.39
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 4.39
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.31
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 4.3
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.29
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.26
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 4.25
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.21
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 4.2
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 4.2
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.19
Regulation of hypoxia-inducible factor activity by ZMYND8 4.18
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.11
Identification of renal resident macrophages across species 4.08
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.07
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 4.04
DRB/GRO-Seq -/+ UV 4.03
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.03
Expression profiling of converted and control dermal BJ fibroblasts 4.0
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 4.0
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.95
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 3.92
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.91
Single-cell analysis of human kidney organoids 3.9
An optimization system for isolating and sequencing of single human colon cancer cells 3.89
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.88
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.85
Transcriptomic analysis of the HOTAIR-regulated genes 3.79
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.79
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 3.75
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 3.75
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.72
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.62
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.5
Unique features and clinical importance of acute alloreactive immune responses 3.49
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.48
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.48
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.47
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 3.44
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.42
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.35
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.32
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 3.31
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.3
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 3.27
Changes in human endometrial gland transcriptome over the window of implantation 3.23
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.21
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.21
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.2
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.18
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.08
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 3.05
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 3.04
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 3.04
Transcription elongation regulates genome 3D structure 2.99
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.97
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 2.96
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 2.92
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.92
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 2.92
RNA-Seq of PRMT1 overexpression ECA109 cells 2.89
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.88
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.88
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.85
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.82
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.81
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.76
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.74
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.74
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.67
RNA-seq data 2.67
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.64
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.49
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.48
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.47
Measure transcript integrity using RNA-seq data 2.43
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.35
Androgen Receptor-regulated genes in prostate cancer cells 2.35
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.34
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.32
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.3
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.3
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.28
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.26
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.26
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.26
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 2.25
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.25
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.24
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 2.23
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.22
Gene expression analysis in response to hypoxic pathway inhibition 2.2
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.15
Effect of ILF3 on translation during homeostasis and the antiviral response 2.14
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.13
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.13
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.13
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 2.09
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.04
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.03
U2AF1 mutations alter splice site recognition in hematological malignancies 2.03
RNA editing in nascent RNA affects pre-mRNA splicing 1.99
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.99
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.97
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.94
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.93
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.91
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.89
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 1.77
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 1.77
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.76
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.76
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.74
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.72
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.72
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 1.67
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.66
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.65
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.62
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.61
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.6
RNA expression analysis upon JMJD1C depletion 1.54
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.54
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.54
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.52
KSDM1b Role in Ewing Sarcoma 1.5
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.49
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.49
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.46
RNA-Seq from human ILC transitional populations 1.46
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.46
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.44
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.44
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.41
Transcriptome of U251 cells overexpression complement component 7 1.38
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.34
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.34
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.32
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.29
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.28
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.27
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.25
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.25
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 1.24
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.23
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.22
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.19
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.17
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.17
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.13
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.13
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.13
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.13
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.13
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.13
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.09
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.08
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.08
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.06
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.05
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.05
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.04
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.04
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.04
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.04
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.04
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.01
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.97
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.95
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.95
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.93
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.91
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.91
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.9
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.9
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.89
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.88
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.88
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.85
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.84
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.84
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.84
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.82
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.82
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.82
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 0.81
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.8
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.8
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 0.79
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.75
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.74
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.7
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.68
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.64
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.57
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.57
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.57
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.56
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.55
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.55
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.51
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.51
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.49
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.45
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.42
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.4
MRTF activates TEAD-YAP target gene expression 0.39
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.36
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.35
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.24
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.23
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.21
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.2
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.18
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.13
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.12
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.12
RNA seq analysis of human Fetal and adult derived Enterospheres 0.05
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.05
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.02
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation